SEC Form 4 · accession 0001140361-17-037507
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Hombach
Director
Period of report
Sep 29, 2017
Accepted (ET)
Oct 3, 2017 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 29, 2017 | A | 3,180 | $0.00 | A | 3,180 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock units granted on September 29, 2017 represent a pro rata share of the 2017 annual award for independent directors and vest on June 6, 2018, the same vesting date for the 2017 annual award for all other independent directors.